Vernalis plc today announces its decision to cease further investment in V3381. An interim review of data from the small pilot study in chronic cough being undertaken in collaboration with Professor ...

Whitbread PLC announced the purchase of 1,000 ordinary shares as part of its ongoing share buy-back programme, aimed at optimizing shareholder value. This transaction underscores its commitment to ...

Future plc ( ($GB:FUTR) ) has provided an announcement. Future plc announced the repurchase of 21,774 of its own ordinary shares on 17 December ...

RELX PLC (the “Company”) announces in compliance with the UK and EU Market Abuse Regulations that it will implement an irrevocable, non-discretionary programme to repurchase its ordinary shares ...

Vesuvius plc ("Vesuvius"), a global leader in molten metal flow engineering and technology, is pleased to announce the commencement today of a further share buyback programme of up to £50 million (the ...

LONDON, UK / ACCESSWIRE / November 1, 2023 / Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF), 'Poolbeg' or the 'Company'), a clinical-stage biopharmaceutical company targeting diseases with a high unmet ...

LEEDS, England, July 25, 2019 /PRNewswire/ -- 4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, today announces an update on its oncology programmes.

LONDON, UNITED KINGDOM / ACCESS Newswire / March 31, 2025 / Gaming Realms plc (AIM:GMR), the developer and licensor of mobile-focused gaming content, announces the commencement of a share buyback ...

LONDON, UK / ACCESSWIRE / June 29, 2023 / Poolbeg Pharma (AIM:POLB, OTCQB:POLBF, 'Poolbeg' or the 'Company'), a clinical-stage biopharmaceutical company focusing on infectious and other prevalent ...

Announcement of Non-Discretionary Share Buyback Programme and Cancellation of Shares held in Treasury RELX PLC (the “Company”) announces in compliance with the UK and EU Market Abuse Regulations that ...